Genovis

Genovis AB is a specialized tools and reagents company operating at the intersection of nanotechnology and biotechnology. It has established a strong niche with its proprietary SmartEnzymes™, particularly the FabRICATOR (IdeS) enzyme, which is used for precise antibody analysis and fragmentation in research, process development, and quality control. The company targets multiple high-growth segments including bioprocess manufacturing, gene therapy, and genomics, providing essential research-use-only tools to accelerate therapeutic development. While not a therapeutic developer itself, Genovis's enabling technologies are critical components in the workflows of biopharmaceutical companies advancing novel treatments.

SmartEnzymes™ platform featuring proprietary, engineered enzymes like FabRICATOR® (IdeS) for specific protein cleavage, antibody analysis, and biologics manipulation. Supports applications in research, bioprocess, gene therapy, and genomics.

Genovis competes in the life science tools and reagents market against large players like Thermo Fisher Scientific and Merck KGaA, as well as smaller specialty enzyme companies. Its competitive advantage lies in the specificity and niche application expertise of its SmartEnzymes, particularly in antibody fragmentation and analysis.